Antibiotics: Conflict and Communication in Microbial Communities

Similar documents
Dier & Kruid Prof. Dr. J. Fink-Gremmels DVM, PhD, Dip ECVPT

Testing Soil Microbes for Antibiotic Production

towards a more responsible antibiotics use in asian animal production: supporting digestive health with essential oil compounds TECHNICAL PAPER

WILDLIFE HEALTH AUSTRALIA SUBMISSION: STAKEHOLDER CONSULTATION - DEVELOPING A NATIONAL ANTIMICROBIAL RESISTANCE STRATEGY FOR AUSTRALIA

Exploration of the Disinfection Hierarchy. Emily Mitchell, Chief Antimicrobials Branch

WILDLIFE HEALTH AUSTRALIA (WHA) SUBMISSION: DRAFT NATIONAL ANTIMICROBIAL RESISTANCE STRATEGY FOR THE AUSTRALIAN ANIMAL SECTOR

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

VetBact culturing bacteriological knowledge for veterinarians

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

Antimicrobial Selection to Combat Resistance

Routine Drug Use in Livestock and Poultry What Consumers Can Do. Food Safety and Sustainability Center at Consumer Reports

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary

Outcome of the Conference Towards the elimination of rabies in Eurasia Joint OIE/WHO/EU Conference

Antimicrobial Resistance Initiative

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

UDC: : :579.22/ :615.28

What Canadian vets need to know and explain about antimicrobial resistance

Randall Singer, DVM, MPVM, PhD

THE COST OF COMPANIONSHIP

Mechanisms and Pathways of AMR in the environment

Good governance and the evaluation of Veterinary Services

INFECTIOUS DISEASE Symposium Proceedings

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Global Food Supply Chain Risks. Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain

ANTIBIOTIC RESISTANCE. Seeking solutions in a time of growing concern

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

FACULTY OF VETERINARY MEDICINE

BIOL 2900 D 4.00 Microbiology in Health/Disease

Course: Microbiology in Health and Disease

Course: Microbiology in Health and Disease Office Hours: Before or after Class or by appointment

Informing Public Policy on Agricultural Use of Antimicrobials in the United States: Strategies Developed by an NGO

ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE: CAUSES AND POSSIBLE SOLUTIONS

Approved by the Food Safety Commission on September 30, 2004

EFSA Scientific Opinion on canine leishmaniosis

Please distribute a copy of this information to each provider in your organization.

Visit ABLE on the Web at:

Promoting One Health : the international perspective OIE

LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health

Understanding and prevention of transmission of antibiotic resistance between bacterial populations and One Health reservoirs

Antimicrobial use in poultry: Emerging public health problem

CONFLICT OF INTEREST ANTIMICROBIAL LOCK SOLUTIONS INCREASE BACTEREMIA

Typhoid fever - priorities for research and development of new treatments

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

Risk analysis of antimicrobial use in aquaculture Peter Smith

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Controlling Salmonella in Meat and Poultry Products

A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013

Dr. Amy Pruden, Ph.D. W. Thomas Rice Professor Department of Civil and Environmental Engineering. Global Change Center Virginia Tech

TREAT Steward. Antimicrobial Stewardship software with personalized decision support

Lecture 11 Wednesday, September 19, 2012

Fate and Transport of Hormones & Antimicrobials

The Role of Academic Veterinary Medicine in Combating Antimicrobial Resistance

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco

Application of sewage in pisciculture in order to augment fish production has been an

E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK

Antimicrobial agents. are chemicals active against microorganisms

DO NOT WRITE ON or THROW AWAY THIS PAPER!

and suitability aspects of food control. CAC and the OIE have Food safety is an issue of increasing concern world wide and

Antimicrobial Resistance

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

American Veterinary Medical Association

Surveillance of AMR in PHE: a multidisciplinary,

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Principles of Antimicrobial therapy

An#bio#cs and challenges in the wake of superbugs

Mendelian Genetics Using Drosophila melanogaster Biology 12, Investigation 1

funded by Reducing antibiotics in pig farming

Safety of Lactic Starter Cultures used in Algerian Dairy Industry Case Study: Antibiotic Resistance

AN APPLIED CASE STUDY of the complexity of ecological systems and process: Why has Lyme disease become an epidemic in the northeastern U.S.

Commercial Challenges: Perspectives from Big Pharma

Correlation of. Animal Science Biology & Technology, 3/E, by Dr. Robert Mikesell/ MeeCee Baker, 2011, ISBN 10: ; ISBN 13:

Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014

Hopkins Microbiology Course Morning Lecture Schedule Hopkins Marine Station, Agassiz 10 Week of Monday, June 17, 2013

Bacteriology and Mycology Course Specifications ( ) A. BASIC INFORMATION B. PROFESSIONAL INFORMATION

Author - Dr. Josie Traub-Dargatz

A-l. Students shall examine the circulatory and respiratory systems of animals.

Experience on Integrated Surveillance of AMR at Country Level : AGISAR Country Pilot Projects and The ESBL E.coli Tricycle Project

time and the parasite had an easy fight through its immune system and eventually damaged it enough to the point of depletion of life.

Tel: Fax:

The promise of aquaculture and the challenge of antimicrobial use

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

WILDLIFE DISEASE AND MIGRATORY SPECIES. Adopted by the Conference of the Parties at its Tenth Meeting (Bergen, November 2011)

Antibiotic Resistance

ANTIBIOTICS IN AQUACULTURE: A (FISH) VETERINARIAN S PERSPECTIVE

American Association of Feline Practitioners American Animal Hospital Association

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

OIE international standards on Rabies:

Antibiotic Resistance

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

Abstract. Introduction

6. The lifetime Darwinian fitness of one organism is greater than that of another organism if: A. it lives longer than the other B. it is able to outc

Boosting Bacterial Metabolism to Combat Antibiotic Resistance

Reading Science! Name: Date: Darwin s Fancy with Finches Lexile 1190L

Transcription:

Antibiotics: Conflict and Communication in Microbial Communities Antibiotics mediate species interactions in natural habitats, affecting the dynamics of microbial coevolution Daniel C. Schlatter and Linda L. Kinkel SUMMARY The discovery that microbes produce antibiotic compounds that kill or inhibit other microbes revolutionized modern medicine by offering a means to treat microbial infections. Thus, the golden age of antibiotic discovery began when hundreds of antibiotics from diverse microbial genera were characterized for their effıcacy in controlling pathogens and the infections they cause. When used at subinhibitory concentrations, however, antibiotics can alter microbial gene expression, suggesting that they also act as signaling compounds. The threat of a postantibiotic era in human medicine is galvanizing another search for novel antibiotics, raising questions about what ecological conditions are likely to lead to novel or inhibitory phenotypes. Meanwhile, some experts are also seeking to identify environmental reservoirs of antibiotic resistance genes, while wondering We lack insight into the dynamics of antibiotic inhibitory and resistance phenotypes and their roles in mediating interactions among microbial species in natural environments. Antibiotics can act as weapons, mediating antagonistic interactions, or signals, mediating a broader range of antagonistic, neutral, manipulative, or synergistic interactions. Both the role of antibiotics and the interactions they mediate are critical to the coevolutionary dynamics of interacting populations. Fitness tradeoffs constrain the capacity for individual bacterial populations to be efficient at resource use, highly inhibitory to other microbes, and broadly resistant to antibiotics at the same time. Unraveling the phenotypic characteristics of interacting microbial populations provides guidance for discovering antibiotics, managing microbial communities, and identifying factors that maintain antibiotic resistance in these populations. what maintains antibiotic resistance in natural habitats. Similarly, agricultural scientists, who are interested in managing soil microbes as an alternative means to inhibit plant pathogens and reduce reliance on pesticides, do not know what selects for broadly antagonistic communities of soil microorganisms. Recent research in our lab and by others is shedding light on how antibiotics mediate species interactions in natural habitats and on how they affect the dynamics of microbial coevolution. Insights into the specifıc roles of antibiotics in naturally occurring communities can not only lead us to antibiotic discoveries, but may help explain how distinct phenotypic structures are generated and how to better manage microbial communities for specifıc functions. Antibiotics as Weapons among Microorganisms Antibiotics act as weapons in mediating microbial species interactions in a variety of habitats. For example, antibiotic-producing Pseudomonas, Streptomyces, Bacillus, and Trichoderma spp. are abundant in plant disease-suppressive soils, and these microorganisms are used widely as inoculants against bacterial, fungal, and oomycete plant pathogens (Fig. 1). Similarly, fungus-farming ants form symbioses with antibiotic-producing bacteria in the genus Pseudonocardia to protect their gardens against infections. Such associations with microorganisms appear to be common among insects and marine sponges, reinforcing the idea that antibiotics act as weapons in natural communities. In these mutualisms, the immediate fıtness 282 Microbe Volume 9, Number 7, 2014

FEATURE ARTICLE FIGURE 1 Antibiotics produced by Streptomyces can inhibit the growth of overlaid Streptomyces (A) or Bacillus (B). Addition of antibiotic-producing Streptomyces to soil can significantly reduce disease and enhance alfalfa growth (C, non-inoculated control; D, inoculated with antibiotic-producing Streptomyces; Xiao et al., 2002). benefıts of antibiotics accrue not to the microbe, but to a third party either a symbiotic plant, ant, or sponge consistent with complex ecological and evolutionary dynamics. While some studies document benefıts of antibiotic production to bacterial fıtness in complex microbial communities, they say little as to how antibiotics enhance fıtness. We reasoned that, if antibiotic weapons confer any direct benefıts to the producer, then selection should favor antibiotics that are most active against sympatric competitors that is, similar species from nearby habitats. Focusing specifıcally on Streptomyces, gram-positive bacteria that are prolifıc producers of antibiotics, we tested whether antibiotic inhibition is greater among microbes from the same (sympatric) or different (allopatric) locations in soil. We fınd that sympatric Streptomyces isolates are more inhibitory against one another than are allopatric isolates, Microbe Volume 9, Number 7, 2014 283

suggesting that antibiotics serve as weapons that confer fıtness benefıts to bacteria that produce them. Further evidence that antibiotics mediate interactions between competitive species comes from studying differences between resource use and inhibition among sympatric and allopatric Streptomyces populations. Antibiotic weapons are broadly assumed to mediate competition for resources. If so, antibiotics should target resource competitors, and selection should favor antibiotics that are most inhibitory towards the strongest competitors for resources. Among a collection of 69 Streptomyces isolates, we determined the niche overlap, or similarity in resource use preferences, among pairwise isolate combinations when they were grown on 95 carbon sources to measure resource competition. Among sympatric but not allopatric Streptomyces isolates, those that had greater niche overlap inhibit one another more than isolates with less niche overlap. Thus, within sympatric, coevolved microbial populations, antibiotics inhibit the strongest resource competitors, affırming a specifıc role for antibiotics in mediating microbial resource competition to enhance fıtness of antibiotic producers. Antibiotics Acting as Signals among Microorganisms Amid substantial evidence for antibiotics being weapons, recent research also makes a compelling case for antibiotics acting as signals. At subinhibitory concentrations, antibiotics modulate a wide variety of functions, including stress response, metabolism, biofılm formation, and virulence among diverse bacterial taxa. These and other examples led to the hypothesis that antibiotics in nature act predominantly as signals, mediating species interactions. However, studying antibiotics in natural habitats is diffıcult because of inherent challenges in manipulating their concentrations in situ. To address such questions, we studied the effects of subinhibitory antibiotics on competitive interactions among diverse Streptomyces isolates in vitro. Specifıcally, we analyzed the effects of subinhibitory concentrations of fıve different antibiotics on nutrient use and resource competition for 72 Streptomyces isolate pairs. Although responses vary from one antibiotic to another, exposing some Streptomyces to subinhibitory concentrations of antibiotics leads to signifıcant shifts in resource use. In some cases, we saw substantially reduced resource competition for 20 40% of isolate combinations, depending upon the specifıc antibiotic. Thus, antibiotics may mediate competition to increase competitor fıtness, while reducing fıtness in others. In this way, antibiotic signals alter the outcome of microbial resource competition, with signifıcant implications for the dynamics of selection for inhibitory, resistance, and resource use phenotypes among coexisting populations. Antibiotic Mixed Messages: Implications for Microbial Coevolutionary Dynamics Because antibiotics can act as both weapons and signals, they can have a substantial impact on the trajectories of coexisting populations in particular soil settings. While antibiotic weapons can provide fıtness benefıts to producer species, these molecules simultaneously exert strong selection pressures for resistance to develop in susceptible populations. Resistance to antibiotics is widely distributed in natural habitats and may be readily acquired through horizontal gene transfers or by mutations. When resistance to one antibiotic spreads within a community, selection will favor microbes that can produce rare or novel antibiotics to which there is little resistance in targeted competitors. Reciprocal selection may thus generate a coevolutionary arms race between antibioticinhibited and -resistant populations in which interacting populations accumulate ever-greater capacities to produce or resist antibiotics (Fig. 2). Microbial communities that support intense competition and are coevolutionary hotspots are likely to maintain populations with diverse antibiotic inhibitory and resistance phenotypes. These communities may be especially fruitful targets for the discovery of novel antimicrobial compounds and may also be highly desirable to cultivate within agricultural soils, where an important goal is to inhibit pathogens that infect valuable crops. However, although there is evidence antibiotic inhibitory capacities accumulate in some microbial communities, sustained antibiotic arms races are likely to be constrained by the costs of maintaining complex antibiotic production and resistance capacities. Niche differentiation offers a distinct coevolutionary pathway within coexisting populations 284 Microbe Volume 9, Number 7, 2014

FIGURE 2 Hypothesized coevolutionary trajectories of microbial populations mediated by antibiotic interactions. (A) Antibiotics have the potential to serve as weapons or signals depending in part on the concentrations at which they mediate interactions. Antibiotics that act at high concentrations by inhibiting growth of competitors are considered weapons, while antibiotics that function at low concentrations to modulate gene expression in competitors are considered to be signals. (B) Antagonistic or arms race coevolution is hypothesized to produce microbial populations that are highly antagonistic, and use antibiotics as weapons at the cost of growth efficiency. (C) Niche differentiation, or character displacement, represents an alternative coevolutionary trajectory in which antibiotics may serve as signals to mediate resource use, or play little role in mediating species interactions. This trajectory will result in coexisting populations of non- or weakly antagonistic, niche-differentiated, highly-efficient resource specialists. (D) Antibiotic signals may influence virulence, motility, or other gene targets, with the potential to induce diverse outcomes. For example, enhanced microbial virulence may fundamentally alter resource availability to microbial pathogens, changing the microbial niche in ways that will influence species interactions. that may reduce the costs of inhibitory and resistance phenotypes. Because antibiotic weapons target competitor species with similar resource use preferences, coevolutionary character displacement via niche differentiation may reduce or eliminate antibiotic inhibitory phenotypes. Thus, rather than ever-more-antagonistic antibiotic-producing competitors, selection may favor resource-specialized microbial populations that avoid producing costly antibiotics and minimize resource competition. These resource specialists are expected to use resources more effıciently and have greater fıtness relative to generalist populations. Further, in the absence of resource competition, antibiotics may confer little fıtness benefıt and thus be lost from populations. The parallel processes of niche differentiation and loss of costly antibiotic-producing phenotypes suggest a coevolutionary trajectory leading to a community dominated by effıcient but nonantagonistic resource specialists. These populations likely maintain some level of antibiotic resistance to protect against antibiotic-producing antagonists. If antibiotic weapons induce either an arms race or niche differentiation, what are the effects of antibiotic signals on microbial coevolution? More specifıcally, how might such signals influence the accumulation of inhibitory and resistance phenotypes or resource use preferences? For competing populations in which antibiotic signals reduce competition by altering patterns of resource use, antibiotic signals may reinforce coevolutionary niche differentiation among Microbe Volume 9, Number 7, 2014 285

FIGURE 3 habitat stability will also influence coevolutionary trajectories. Coevolutionary Outcomes and Fitness Tradeoffs Fitness impacts of antibiotic weapons and signals to the producing organism vary with concentrations. Relative fitness benefits of antibiotic weapons (A) to the producer will be greatest when antibiotics are present at the minimum concentrations that inhibit susceptible competitors. In contrast, the effects of antibiotic signals on the signal-producer will be greatest at low concentrations that are sufficient for effective signaling, but much less than required for inhibition. Antibiotics that serve dual functions as signals and weapons will impact fitness across a wide range of concentrations (C). competitors. In contrast, antibiotic signals that increase the signifıcance of competition to microbial fıtness and that reduce capacity of a competitor to metabolize preferred resources may select for variants of the signal-producer that produce greater quantities of that antibiotic signal (Fig. 2). This outcome could provide an important transition between antibiotic signals that are produced at very low concentrations and antibiotic weapons that are produced at high concentrations. For example, signaling interactions that reduce the competitive fıtness of a sympatric population may be a fırst step in initiating an arms race. However, in cases where a signal enhances fıtness of a competitor at a cost to its producer, variants that no longer produce the antibiotic likely will be selectively enriched, eliminating a role for that antibiotic in coevolutionary interactions. Whether antibiotic signals promote coevolutionary trajectories of niche differentiation versus an arms race will depend on whether signals mediate fıtness-enhancing or -reducing interactions between the signal producer and its targets (Fig. 3). Other factors, including habitat characteristics, frequencies of microbial invasion or habitat disturbance, microbial phylogeny, and Arms races or niche differentiation presumably yields populations of antagonistic competitors or growth-effıcient resource specialists, respectively. The role of antibiotics in species interactions differs fundamentally for these two different life histories. Antagonistic competitors rely on antibiotics as weapons, while growth-effıcient nutrient specialists use antibiotics as signals, if at all. This picture, however, presumes that populations can be either effıcient and niche specialized or highly antagonistic, but not both. However, tradeoffs between antibiotic production or resistance and other microbial life histories remain relatively unexplored. While fear of highly virulent and simultaneously highly antibiotic-resistant pathogens remains widespread, there is little information on the cumulative costs of resistance or inhibition for microbial populations. Both antibiotic production and resistance can impose fıtness costs in the laboratory, but compensatory mutations might reduce or eliminate the costs of antibiotic resistance for microbial pathogens in clinical settings. Moreover, antibiotic biosynthesis is often tightly regulated so that antibiotics are produced only in response to resource limitation, microbial signals, or at particular life stages, which may limit the metabolic costs of antibiotic production to situations where they are needed. Can microbes solve the jack-of-all-trades, master-of-none dilemma through compensatory mutations and tightly regulated gene expression? Our studies of naturally occurring Streptomyces populations shed light on the potential for fıtness tradeoffs to limit life history strategies. Specifıcally, if fıtness tradeoffs constrain the capacity for a microbe to grow effıciently while being highly antagonistic, then microbes that produce more antibiotics or that can inhibit a wider range of target populations theoretically will grow less effıciently on average than organisms that are less antagonistic. Among a random collection of 263 Streptomyces from prairie soil, we found that isolates that were highly antagonistic (inhibited all 10 target Streptomyces) grew signifıcantly less effıciently on average (22% less growth) than did 286 Microbe Volume 9, Number 7, 2014

FIGURE 4 Antibiotic-mediated networks of interactions within natural communities can be complex. In these networks each node represents an individual microbial population, and vectors represent direct interactions between populations. Antibiotic weapons (red lines) or antibiotic signaling interactions (blue lines) will mediate interactions between population pairs, but may also influence populations indirectly. Thus, for example, species B may directly inhibit species C, but species D may indirectly influence fitness of species C by limiting the potential for species D to inhibit species C. Keystone species (e.g. species D) may have especially large direct and/or indirect impacts on species interactions and coevolution within a community. isolates that were unable to inhibit any of 10 target isolates. Thus, in these naturally occurring populations, there is evidence for fıtness tradeoffs between antibiotic-inhibitory phenotypes and growth effıciency, affırming the likelihood of an either/or coevolutionary trajectory for competing populations. Antibiotic Interactions within Complex Communities Microbial responses to antibiotics typically are analyzed within the context of pairwise or perhaps three-way species interactions. However, microbes live in complex communities, harboring an astounding phylogenetic and functional diversity in which multiple antibiotics serve simultaneously as weapons and signals amid intricate webs of interactions (Fig. 4). In this context, an antibiotic may be mutualistic, synergistic, or manipulative, acting as either a weapon or a signal depending upon the interacting species. Moreover, among coexisting populations, there are likely to be keystone taxa that have disproportionately large fıtness impacts and thus play a more central role in determining ecological and coevolutionary dynamics within the community. Studying coevolved populations in natural habitats offers a powerful resource for expanding our understanding of these complex dynamics. The amazingly diverse antibiotic arsenal is critical not only to the biology of microbes, but to management of human, animal, and plant diseases. A comprehensive understanding of the ecology of antibiotics will help us to develop new means for discovering novel antibiotics while better capitalizing on the diversity of natural products, effectively managing soil communities to suppress plant diseases, and analyzing microbial dynamics among naturally occurring populations. Daniel C. Schlatter is a postdoctoral associate and Linda L. Kinkel is a professor in the Department of Plant Pathology, University of Minnesota, St. Paul. Acknowledgements We gratefully acknowledge current and former members of our research group, including Patricia Vaz, Matt Bakker, and Lindsey Hanson, for sustained thoughtful and stimulating discussions. Current and past research support from the Agricultural and Food Research Initiative of the USDA National Institute of Food and Agriculture and the U.S. National Science Foundation is gratefully acknowledged. Suggested Reading Bernier, S. P., and M. G. Surette. 2013. Concentrationdependent activity of antibiotics in natural environments. Frontiers Microbiol. doi:10.3389/fmicb.2013. 00020 Hibbing, M. E., C. Fuqua, M. R. Parsek, and S. Brook Peterson. 2010. Bacterial competition: surviving and thriving in the microbial jungle. Nature Rev. Microbiol. 8:15 25. Kinkel, L. L., M. G. Bakker, and D. C. Schlatter. 2011. A coevolutionary framework for managing disease-suppressive soils. Annu. Rev. Phytopathol. 49:47 67. Kinkel, L. L., D. C. Schlatter, K. Xiao, and A. D. Baines. Sympatric inhibition and niche differentiation suggest alternative coevolutionary trajectories among Strep- Microbe Volume 9, Number 7, 2014 287

tomycetes. ISME J doi:10.1038/ismej.2013.175, in press. Thompson, J. N. 2005. The geographic mosaic of coevolution. University of Chicago Press, Chicago. Vaz-Jauri, P., M. G. Bakker, C. E. Salomon, and L. L. Kinkel. 2013. Subinhibitory antibiotic concentrations alter nutrient utilization and niche overlap among Streptomyces spp. PLoS One. doi:10.1371/journal. pone.0081064 Yim, G., H. H. Yang, and J. Davies. 2007. Antibiotics as signalling molecules. Phil. Trans. R. Soc. B. 362:1195 1200. Expert advice from the American Academy of Microbiology brought to your classroom. Freely available: bit.ly/asmfaq Topics include: In uenza E.coli Oil Spills West Nile Virus Adult Vaccina on 1752 N Street NW Washington, DC 20036 202-942-9323 academy@asmusa.org 288 Microbe Volume 9, Number 7, 2014